AH
adi haber
Novocure Ltd
Israel
- Frontiers in Oncology
- Gynecological Oncology
- Research Topics
- PARP inhibitors resistance: new insights in ovarian cancer therapy
PARP inhibitors resistance: new insights in ovarian cancer therapy
5,516
Total downloads
20k
Total views and downloads
37 Authors
- AC
an coosemans
Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven
Belgium
- EP
eunhyang park
Department of Pathology, Yonsei University College of Medicine
Republic of Korea
- ED
eyal dor-on
Novocure Ltd
Israel
- IV
ignace vergote
Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, KU Leuven
Belgium
- JL
jung-yun lee
Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine
Republic of Korea
- KG
ketankumar gajjar
Department of Gynaecological Oncology, Nottingham University Hospitals
United Kingdom
- LC
laetitia collet
Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB)
Belgium
- ML
michalis liontos
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital
Greece
- MG
moshe giladi
Novocure Ltd
Israel
- NC
nicolas chopin
Department of Surgery, Centre Léon Bérard
France
- OF
oraianthi fiste
Oncology Unit, Third Department of Internal Medicine and Laboratory, National and Kapodistrian University of Athens, Sotiria General Hospital
Greece
